Search for: "State v. Perrigo" Results 21 - 40 of 42
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Oct 2010, 1:20 pm by Bexis
Levine involved a traditional state-law claim and did not affect the inability of state-law plaintiffs to sue over FDCA violations having no parallel in state law.Lofton v. [read post]
8 Oct 2019, 9:44 am by Dennis Crouch
 Perrigo Company, No. 19-450 (setting aside jury verdicts) Neology, Inc. v. [read post]
7 Sep 2010, 6:10 pm by Kelly
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen, ‘yes’ to… [read post]
19 Jun 2008, 12:00 pm
Without preemption, however, state juries are asked to do just that. [read post]
13 Jul 2023, 9:16 pm by Tyler Hoguet
Supreme Court’s ruling in Biden v. [read post]
22 Dec 2011, 11:59 am by Bexis
  All this in a state – Illinois – where the highest court forbids FDCA-based common-law causes of action (see Martin v. [read post]
13 May 2021, 2:24 pm by Kevin LaCroix
 Seeking to capitalize on the forfeiture rule, defendants in the high-profile Perrigo securities litigation are now seeking dismissal of direct actions brought by a half dozen institutional investors before class certification was issued.[9]  The Perrigo court, which is also located in the District of New Jersey, has not yet issued a ruling on the issue. [read post]
9 Jan 2014, 1:37 pm
Md. 2012) (same); New York State Pesticide Coalition, Inc. v. [read post]
2 Nov 2011, 2:00 am by Marie Louise
Novartis Vaccines & Diagnostics (Pharma Patents) US: CAFC Affirms district court de novo review in section 146 action: Streck v. [read post]
12 Sep 2023, 5:00 am by James Jolin
Although there has been a great deal of conversation about this decision in relation to the Dobbs v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
17 Jun 2010, 6:57 am by Rebecca Tushnet
In past downturns, we haven’t seen ads like this (v. something staplegunned to a telephone pole). [read post]
19 Sep 2008, 6:00 pm
: (Danny Weitzner - Open Internet Policy), United States: How many lines is de minimis? [read post]
28 Dec 2023, 9:05 pm by Noah Brown
Frederique Welgryn, Perrigo’s Global Vice President for Women’s Health, called FDA’s approval “a groundbreaking expansion for women’s health” in the United States. [read post]